Jörg T. Hartmann

机构：Francis Hospital

发表论文 115 篇 · 总被引 14672 次 · h-index 40

代表论文

• Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial (2019 · The Lancet · 被引 2703)
• Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer (2013 · JAMA · 被引 1820)
• Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial (2014 · The Lancet Oncology · 被引 1193)
• One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor (2012 · JAMA · 被引 984)
• Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial (2009 · The Lancet Oncology · 被引 971)
• Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial (2012 · The Lancet Oncology · 被引 511)